Emergent Biosolutions Stock Price on December 12, 2024
| EBS Stock | USD 8.10 0.04 0.50% |
Below is the normalized historical share price chart for Emergent Biosolutions extending back to November 15, 2006. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Emergent Biosolutions stands at 8.10, as last reported on the 23rd of December, with the highest price reaching 8.35 and the lowest price hitting 7.70 during the day.
If you're considering investing in Emergent Stock, it is important to understand the factors that can impact its price. Emergent Biosolutions appears to be relatively risky, given 3 months investment horizon. Emergent Biosolutions secures Sharpe Ratio (or Efficiency) of 0.0996, which denotes the company had a 0.0996% return per unit of risk over the last 3 months. By reviewing Emergent Biosolutions' technical indicators, you can evaluate if the expected return of 0.62% is justified by implied risk. Please utilize Emergent Biosolutions' Downside Deviation of 5.61, coefficient of variation of 1523.79, and Mean Deviation of 4.46 to check if our risk estimates are consistent with your expectations.
At this time, Emergent Biosolutions' Other Stockholder Equity is comparatively stable compared to the past year. Common Stock Total Equity is likely to gain to about 120.8 K in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 41.4 M in 2024. . Price To Sales Ratio is likely to drop to 0.11 in 2024. Price Earnings Ratio is likely to gain to -0.15 in 2024. Emergent Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of November 2006 | 200 Day MA 6.2573 | 50 Day MA 8.6254 | Beta 1.574 |
Emergent |
Sharpe Ratio = 0.0996
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | EBS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.22 actual daily | 55 55% of assets are less volatile |
Expected Return
| 0.62 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Emergent Biosolutions is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Emergent Biosolutions by adding it to a well-diversified portfolio.
Price Book 0.8633 | Enterprise Value Ebitda 46.4191 | Price Sales 0.39 | Shares Float 53.1 M | Wall Street Target Price 12 |
Related Headline
Fate Therapeutics Headline on 12th of December 2024
Disposition of 6022 shares by Redmile Group, Llc of Fate The... by finance.yahoo.com
Filed transaction by Fate Therapeutics Director, 10 Percent Owner: . Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Emergent Biosolutions Valuation on December 12, 2024
It is possible to determine the worth of Emergent Biosolutions on a given historical date. On December 12, 2024 Emergent was worth 8.54 at the beginning of the trading date compared to the closed value of 8.69. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Emergent Biosolutions stock. Still, in general, we apply an absolute valuation method to find Emergent Biosolutions' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Emergent Biosolutions where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Emergent Biosolutions' related companies.
| Open | High | Low | Close | Volume | |
| 8.77 | 8.77 | 8.32 | 8.57 | 792,994 | |
12/12/2024 | 8.54 | 8.89 | 8.51 | 8.69 | 789,276 |
| 8.81 | 8.87 | 8.35 | 8.48 | 1,092,646 |
| Backtest Emergent Biosolutions | | | Emergent Biosolutions History | | | Emergent Biosolutions Valuation | Previous | Next |
Emergent Biosolutions Trading Date Momentum on December 12, 2024
| On December 13 2024 Emergent Biosolutions was traded for 8.48 at the closing time. Highest Emergent Biosolutions's price during the trading hours was 8.87 and the lowest price during the day was 8.35 . The net volume was 1.1 M. The overall trading history on the 13th of December 2024 contributed to the next trading period price depreciation. The overall trading delta to the next next day price was 2.42% . The overall trading delta to current price is 7.25% . |
Emergent Biosolutions Fundamentals Correlations and Trends
By evaluating Emergent Biosolutions' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Emergent Biosolutions' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Emergent financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Emergent Biosolutions Stock history
Emergent Biosolutions investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Emergent is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Emergent Biosolutions will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Emergent Biosolutions stock prices may prove useful in developing a viable investing in Emergent Biosolutions
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 51.2 M | 41.4 M | |
| Net Loss | -257.4 M | -244.5 M |
Emergent Biosolutions Stock Technical Analysis
Emergent Biosolutions technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Emergent Biosolutions Period Price Range
Low | December 23, 2024
| High |
0.00 | 0.00 |
Emergent Biosolutions cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Emergent Biosolutions December 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Emergent Biosolutions stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Emergent Biosolutions shares will generate the highest return on investment. By undertsting and applying Emergent Biosolutions stock market strength indicators, traders can identify Emergent Biosolutions entry and exit signals to maximize returns
Emergent Biosolutions Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Emergent Biosolutions' price direction in advance. Along with the technical and fundamental analysis of Emergent Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Emergent to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0607 | |||
| Jensen Alpha | 0.3436 | |||
| Total Risk Alpha | 0.2274 | |||
| Sortino Ratio | 0.0681 | |||
| Treynor Ratio | 0.1481 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Emergent Stock Analysis
When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.